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Abstract
AKAP5 (also referred to as AKAP150 in rodents and AKAP79 in humans) is a scaffolding protein that is highly expressed in
neurons and targets a variety of signaling molecules to dendritic membranes. AKAP5 interacts with PKA holoenzymes
containing RIIa or RIIb as well as calcineurin (PP2B), PKC, calmodulin, adenylyl cyclase type V/VI, L-type calcium channels,
and b-adrenergic receptors. AKAP5 has also been shown to interact with members of the MAGUK family of PSD-scaffolding
proteins including PSD95 and SAP97 and target signaling molecules to receptors and ion channels in the postsynaptic
density (PSD). We created two lines of AKAP5 mutant mice: a knockout of AKAP5 (KO) and a mutant that lacks the PKA
binding domain of AKAP5 (D36). We find that PKA is delocalized in both the hippocampus and striatum of KO and D36 mice
indicating that other neural AKAPs cannot compensate for the loss of PKA binding to AKAP5. In AKAP5 mutant mice, a
significant fraction of PKA becomes localized to dendritic shafts and this correlates with increased binding to microtubule
associated protein-2 (MAP2). Electrophysiological and behavioral analysis demonstrated more severe deficits in both
synaptic plasticity and operant learning in the D36 mice compared with the complete KO animals. Our results indicate that
the targeting of calcineurin or other binding partners of AKAP5 in the absence of the balancing kinase, PKA, leads to a
disruption of synaptic plasticity and results in learning and memory defects.
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Introduction
Mammalian cells have evolved a high degree of spatial and
temporal control of signaling pathways. This specificity depends
on the creation of intracellular microdomains containing signaling
molecules tethered on scaffolding molecules. A kinase anchoring
proteins (AKAPs) are PKA binding proteins that localize PKA and
other signaling molecules to discrete sites in many cells including
neurons. AKAP5, also referred to as AKAP150 in rodents, is an
orthologue of human AKAP79 and bovine AKAP75 and is highly
expressed in brain [1]. This AKAP binds RII subunits of PKA, as
well as other signaling molecules including the calcium activated
phosphatase PP2B/calcineurin [2], calmodulin [3], and PKC [4].
Thus, AKAP5 can allow for crosstalk between signaling molecules
that are co-targeted as well as provide tight control of both
phosphorylation and dephosphorylation of substrates present near
the scaffold complex [5].
The physiological role of PKA targeting by AKAPs has been
studied in neuronal cell culture and tissue slice by using the
peptide, Ht-31, to disrupt endogenous AKAP/PKA interactions.
The limitation of this method is that there are many AKAPs
within a given cell, and Ht-31 nonspecifically disrupts all AKAP-
PKA interactions. Genetic approaches can target specific AKAPs
and we have generated AKAP5 knockout (KO) mice and AKAP5
PKA-binding mutant (D36) mice (AKAP5 accession number
NP_001094941).
In neurons, AKAP5 targets PKA to dendritic compartments [6]
and interacts with MAGUK proteins within the postsynaptic
density (PSD) [7,8]. More recently AKAP5 has been shown to
directly interact with other neuronal receptors and ion channels
located in the PSD, including the b-adrenergic receptor [9,10],
adenylate cyclases Type V/VI [11], the L-type calcium channel
[12,13], potassium channels, and acid sensing ion channels
[7,12,14,15,16,17]. AKAP5 has been shown to indirectly interact
with and promote GluR1 phosphorylation on Ser845 by PKA [7]
and on Ser831 by PKC [18]. GluR1 phosphorylation on these two
sites correlates with synaptic plasticity and learning in mice [19].
Here we demonstrate that AKAP5 is required to localize both
RIIa and RIIb containing holoenzymes to the dendritic regions of
neurons in the hippocampus and striatum. PKA is dramatically
delocalized within dendrites in both the KO and D36 mice
indicating that no other AKAPs are able to compensate and
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PKA in AKAP5 KO neurons can migrate to and associate with
MAP2, an AKAP abundant in dendritic shafts. Our previous
studies had demonstrated defects in both LTP and LTD in the
D36 mutants and here we demonstrate that, despite similar PKA
delocalization in KO and D36 mice, the electrophysiological
phenotypes associated with the D36 mutant are not shared by the
KO. This gain of function effect of the D36 mutant, which
anchors AKAP5 binding partners but not PKA, correlates with an
effect of the D36 mutation on learning and memory in an operant
learning paradigm that requires reversal learning. We speculate
that the targeting of a phosphatase (calcineurin) in the absence of a
balancing kinase like PKA leads to a disruption of synaptic
plasticity and results in learning and memory defects that are more
severe in the D36 mice than those observed in the complete KO.
Taken together, these results also argue that AKAP5 is primarily
responsible for targeting PKA to dendritic spines and the PSD.
Materials and Methods
All animal procedures were approved by the University of
Washington’s School of Medicine and the University of Iowa
Institutional Animal Care and Use Committee, protocol number
2022-01 in accordance with the NIH Guide for the Care and Use
of Laboratory Animals.
Generation of mouse lines and genotyping
To create the KO mice a neomycin phosphotransferase (neo)
cassette was inserted into BamH1 and BglII sites within the AKAP5
genomic sequence. This replaces most of the AKAP5 coding
sequence with the neo cassette, which is oriented in the opposite
direction from the AKAP5 gene. For the D36 mice, a stop codon
(TAG) was engineered into the gene at the Leu710 position, which
truncates the last 36 amino acids from the full-length protein.
These 36 amino acids contain the PKA binding region. This was
achieved by subcloning a 1.5 kb BglII/SpeI fragment containing
the Leu710 codon from the targeting vector. Site-directed
mutagenesis was performed with the QuickChangeH kit from
StratageneH using Pfu polymerase with the overlapping oligonu-
cleotides: 59-CAGTATGAAACACTCTAGATAGAAACAGAT-
CTTC-39 and 59-AGATGCTGTTTCTATCTAGAGTGTTT-
CATACTGTT-39. The mutated fragment was sequenced to
confirm the desired mutation. This engineered D36 mutation also
introduces an XbaI restriction site that was used for genotyping.
The D36 targeting vector contained the neo cassette flanked by
loxP sites downstream from the AKAP5 sequence. Constructs were
linearized with ClaI and electroporated into R1 ES cells [20].
Targeted ES clones were selected in G418 and identified by
Southern Blot analysis using a 39 external probe. Southern blots
detected SacI (S) fragments of 10 kb in wild type, 12.4 kb in KO,
and 11 kb in D36 recombinant ES cells. Positive ES cell clones
were selected for injection into blastocysts to produce chimeric
mice that were then bred to C57BL/6 to obtain germ line
transmission. We further crossed D36 F1 offspring to a line of
rosa26-Cre recombinase expressing mice [21], which removed the
neomycin resistance gene leaving a single loxP site. Both the KO
and D36 mouse lines were backcrossed to C57BL/6 (Charles
River) for at least 8 generations before being used for the
behavioral or electrophysiological studies described here.
Fractionation and Western blots
Samples were dounce homogenized and/or sonicated 10:1 v/w
in homogenization buffer containing 250 mM sucrose, 0.1 mM
EDTA, 0.5 mM EGTA, 10 mM DTT, 20 mM Tris, pH 7.6 with
detergents (1% Triton X-100, 0.5% sodium deoxycholate), and
protease and phosphatase inhibitors (1 mg/ml leupeptin, 3 mg/ml
aprotinin, 40 mg/ml soybean trypsin inhibitor, 0.5 mM 4-(2-
aminoethyl) bezenesulfonyl fluoride, 0.1 mM microcystin-LR,
0.2 mM NaF, 0.2 mM orthovanadate). The homogenate was
cleared at 1,0006g for 10 min at 4u. The pellet was discarded and
the supernatant was collected for western blots.
For separation of soluble and particulate fractions, the same
homogenization buffer (without detergents) was used to homog-
enize the tissue in a dounce homogenizer. The supernatant of the
1,0006g centrifugation was collected and recentrifuged at
100,0006g for 30 minutes. The supernatant (S) was collected
and the pellet was washed by resuspension in homogenization
buffer without detergent, spun as above and the supernatant
discarded. The pellet was then resuspended as the particulate
fraction (P) in an equal volume of homogenization buffer with 1%
sodium deoxycholate (DOC) and 1% Triton X-100.
For western blots, protein (20–40 mg) in 1x sample buffer
(62.5 mM Tris?Cl, 2% SDS, 5% glycerol, 0.05% bromophenol
blue, pH 6.8) was separated by SDS/PAGE and transferred to
nitrocellulose (Schleicher & Schuell, Keene, NH) by electropho-
resis. Blots were stained with Ponceau S to verify equal loading of
lanes. Blots were then washed in TBST (100 mM Tris/HCl,
150 mM NaCl, .1% Tween-20, pH 7.2), blocked (5% BSA in
Tris-buffered saline, 0.1% Tween-20) for 2 hours at room
temperature, washed in TBST and probed (2 h room temp or
overnight at 4u C) with the primary antibodies for: anti-C (a gift of
S. S. Taylor, University of California, San Diego), anti-RI
(Transduction Laboratories, Lexington, KY), anti-RIIb (Biomol,
Plymouth Meeting, PA), anti-RIIa, anti-AKAP5 N-19 and C-20
(Santa Cruz Biotechnology, Santa Cruz, CA). After primary
antibody incubation, blots were washed in TBST and incubated
with HRP conjugated secondary antibodies (GE Healthcare UK
Limited, Little Chalfont Buckinghamshire, UK) diluted 1:10000 in
5% blotto (dry milk) TBST and incubated 1–2 hrs at room
temperature. Westerns were exposed to film (Midsci, St. Louis,
Mo) after the ECL reaction (GE Healthcare/Amersham, Little
Chalfont Buckinghamshire, UK).
RII Overlay assay
After blocking, blots were incubated with recombinant RIIb
diluted to 7 nM or 70 nM in 5% BSA/TBST blocking buffer and
incubated with the blots for 2 hrs at room temperature in the
presence of either 0.15 mM Ht-31 anchoring inhibitor peptide
(DLIEEAAVSRIVDAVIEQVKAAGAY) or a control peptide,
Ht-31P (DLIEEAAVSRPVDAVIEQVKAAGAY) (Promega, Ma-
dison WI), which contains a proline that disrupts the RII binding
helix. Blots were washed with TBST, and incubated in primary
antibody against RIIb for 2 hrs at room temp. Subsequent washes
and secondary antibody steps are as in the western blot methods,
except all overlay blocking was done in 5% BSA.
Immunohistochemistry and Confocal Microscopy
Adult mice were anesthetized with pentobarbital and perfused
with PBS (about 40 ml, until fluid is clear) followed by ice cold
PBS-buffered 4% paraformaldehyde (PFA). Brains were dissected
and post fixed in 4% PFA for at least one hour at 4uC, before
being transferred to 25% sucrose and sunk 1–2 days at 4uC. Fixed
mouse brains were frozen in OCT (Miles Inc., Elkhart, IN) at
280uC, and sectioned in a Cryostat (25 mm sections). Sections
were mounted directly to coated Superfrost slides (Fisher
Scientific, Waltham, MA). Sections were washed with PBS (three
times, 5 minutes each) and incubated in blocking buffer (0.1%
BSA, 0.1% Triton X100, 10% serum (from same species as
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room temperature (RT). Sections were incubated in primary
antibody (anti-RIIb: BD Transduction Laboratory, mAb, Cat.
#610625, 1:500 dilution; anti-RIIa: Santa Cruz, rabbit polyclon-
al, Cat. #sc-909, 1:200 dilution; anti-AKAP5 N-19: Santa Cruz,
goat polyclonal, Cat. #sc-6446, 1:500 dilution) diluted in blocking
buffer and incubated overnight at 4uC. Brain sections were washed
with PBS+0.1% Triton X-100 (4–5 times, 5-minute incubations) at
RT (mild shaking). Sections were incubated in secondary
antibodies diluted in blocking buffer for at least one hour (up to
three hours) at RT. Dilutions used were: 1:500-1000, Alexa
fluor488-goat anti-mouse IgG or Alexa fluor568-goat anti-rabbit
IgG. Sections were washed in PBST, and mounted with
Fluoromount (Beckman Coulter, Inc, Fullerton, CA). For
RIIa+AKAP5 staining, the blocking buffer contains normal horse
serum and the secondary antibodies are Alexa Fluor488-donkey
anti-rabbit and Alexa Fluor568-donkey anti-goat IgG (Alexa Fluor
antibodies from Invitrogen Corp, Carlsbad, CA). Confocal
imaging (Leica TCS SP/MP) was conducted at the Keck Imaging
Center of the University of Washington.
Kinase assays
Kinase assays were performed as previously published [22].
Immunoprecipitation
Hippocampal tissue was homogenized in a polytron at 1:10 (w/
v) in 1 mL of ice-cold lysis buffer (10 mM Na2HPO4, 150 mM
NaCl, 5 mM EDTA, 5 mM EGTA, 5 mM NaF, pH 7.4) with the
addition of 1.0% Triton X-100, 0.5% DOC, and 1X protease and
phosphatase Inhibitor Cocktails, cat#P8340, #P2850, Sigma).
The 1,0006g supernatant was collected, protein concentration
determined by BCA Protein Assay (cat#23227, Pierce, USA) and
500 mg of protein was diluted into 1 mL of lysis buffer containing
0.1% Triton X-100 and 1X Protease inhibitor Cocktail.
Antibodies were added and incubated overnight at 4uC followed
by capture with 50 mL of a 50% slurry of Protein G magnetic
beads (DynabeadsH, Invitrogen) for 1 h at 4uC. The beads were
washed three times with lysis buffer containing 0.1% Triton X-100
and the immunoprecipitated proteins were eluted from the beads
with 2X sample buffer. The eluted samples were then separated by
SDS-PAGE and assayed by Western blot. HRP conjugated anti-
mouse and anti-rabbit secondary antibodies were purchased from
Jackson ImmunoResearch (PA, USA). The N-19 polyclonal anti-
AKAP150 antibody (1:500), and polyclonal anti-PKA-RIIa
(1:500), were from Santa Cruz Biotechnology, Inc. (CA, USA).
The monoclonal anti-CaN (1:1000) was purchased from Sigma
(MO, USA). PSD-95 antibody was mouse monoclonal MA1-046
from Thermo Scientific (Waltham MA), GluR2/3 was Chemicon
(now Millipore, Billerica MA) Ab#1506, and MAP2 was sc-12012
from Santa Cruz Biotechnology, Inc (CA, USA).
Electrophysiology
Measurements of hippocampal LTP and LTD were done as
previously described [23,24]. Mice had been backcrossed onto a
C57BL/6 background for at least 8 generations. For LTD, 10–14 day
oldmale mice and their littermate controls were assayed. For LTP,8–
12 week old male mice and littermate controls were assayed.
Water Maze
A hidden platform was submerged 1 cm in a 4-foot diameter
tank and white tempera paint was used to make the water opaque.
Mice were placed in the water maze in one of three random
positions, with each position being the same distance from the
hidden platform. Mice exhibiting ‘‘floating’’ behavior on day 1
were excluded from the study. The maximum time for a trial was 3
minutes. If a mouse did not find the platform at the 3-minute
point, that mouse was scored at 180 seconds, and placed on the
platform for a 10 second period. If a mouse located the platform
before the 180-second period, the time was scored as the time they
touched the platform, and the mouse was allowed to remain on the
platform for 10 seconds. Each mouse had 3 trials per day and the
results for each day were averaged. Spatial learning was assessed
over 9 consecutive days of training. Each mouse had one probe
trial 24 hours after the last training day to assess reference memory
for the platform. Probe trials were two minutes long. GraphicState
2 (Coulbourn Instruments, PA) tracking and analysis software was
used to calculate time spent in each quadrant. Male and female
mice between the ages of 11 and 15 weeks old were used.
Novel Object Recognition
Mice were placed in a circular arena (diameter of 4 feet with a 3
foot wall) with overhead illumination. On days 1 and 2 each mouse
had a 10-minute free run to habituate to the arena. On day 3 each
mouseperformed 3 five minute runsinthearena with 10 min.breaks
between runs as follows: The first run was a free run in the empty
arena (without objects). The second run was in the arena containing
two objects. The time spent at each of the objects was recorded. After
this run, one of the objects was replaced with a novel object, and the
third run was in the arena with this novel object and the previously
explored object. The time spent at each of the objects was again
recorded. The two objects were always placed opposite each other
and 1 foot from the wall. Mice were recorded by video camera.
GraphicState 2 (Coulbourn Instruments) tracking and analysis
software was used to calculate time spent approaching objects.
Operant Boxes
Before the operant box sessions, the mice were weighed to
determine their pretrial weight. All mice were between 6–8 weeks
old at the start of the food restriction. Over a period of 7 days the
mice were fed a restricted diet (2.5 g–3 g daily), which slowly
reduced their weight, until they were at 85% of the pretrial weight.
Mice were weighed daily and maintained at this weight for the
duration of the study. After mice performed in the operant boxes,
they were weighed, and placed in their home cage.
Boxes contained 2 levers, one ‘‘active’’ and the other ‘‘inactive’’,
and 2 nose poke holes on the opposite wall. The food hopper was
between the two levers. Food was dispensed when the ‘‘active
lever’’ was pressed. The box was enclosed so that mice did not see
or hear the experimenter. When the session was activated, there
was an interior house light providing illumination inside the box.
Pressing the active lever produced an auditory tone coupled with
the delivery of 1 food pellet. Pressing the inactive lever caused a
15 sec inactivation of the active lever. During this time out, the
interior light turned off, and pressing either lever had no effect. At
the end of the time out, the interior light turned on, and lever
pressing consequences (food reward or time out) were engaged. All
sessions were 20 minutes long and each animal had 1 session each
day. The schedule was as follows:
Day 1–12: Training. Left lever was active.
Day 13–20: Reversal. Right lever was active. These days are
called days 1–8 of the reversal learning phase.
Results
Generation of KO and D36 mice
To study the role of AKAP5 in behavior and synaptic plasticity,
we created two AKAP5 mutant lines of mice, a null allele, or
Analysis of AKAP5 Mutant Mice
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truncated protein missing the PKA binding domain (D36). The
entire coding region of the rodent Akap5 gene is contained within a
single exon (Fig. 1A). A neomycin phosphotransferase (neo)
cassette was inserted to replace most of the Akap5 coding sequence
to generate the KO allele. Correct targeting was confirmed by
Southern Blot (Fig. 1C). To create the D36 mutant allele, a stop
codon was inserted into the leucine 710 position by site-directed
mutagenesis (Fig. 1B). This truncates the last 36 amino acids,
which contain the PKA binding portion [25]. Because the
downstream neo gene used for selection could interfere with
proper expression of the mutant protein, the floxed neo cassette
was excised by crossing to the rosa26 Cre mice (Cre step in Fig. 1B)
[26], and neo excision was confirmed by Southern Blot (Fig. 1D).
PCR methods were devised to genotype KO and D36 mice. KO
mice were genotyped with two separate PCR reactions; one
reaction amplifies Akap5 sequence contained in the WT allele, and
the other amplifies neo sequences contained in the KO allele
(Fig. 1E). In order to genotype the D36 mice, we developed a PCR
strategy that takes advantage of an XbaI restriction site created by
the mutation at the Leu710 position (denoted ‘‘X’’ in Fig. 1B).
XbaI does not cut the 245 bp PCR product of the WT allele,
whereas the 245 bp PCR product of the D36 allele is cut by XbaI
to generate two fragments of 131 bp and 114 bp in length (Fig. 1F).
Heterozygous mice have both the upper (245 bp) and lower (131/
114 bp) bands.
Weconfirmed that the proteinisabsent intheKOmice (Fig.1G),
and that the mutant protein is expressed in the D36 mice (Fig. 1H).
Consistent with previously published work [6], western blots
demonstrate that the protein is abundant in the brain, and most
abundant in the forebrain, with regions of the striatum showing the
highest levels of expression whereas the cerebellum expresses at
lower levels. N and C-terminal antibodies for AKAP5 demonstrate
the complete absence of protein in the KO (Fig. 1G). As expected,
the D36 protein is expressed but unreactive with the antibody that
recognizes the deleted C-terminus of AKAP5 (Fig. 1H).
Type II PKA is mislocalized in AKAP5 KO and D36 mice
In the brain, AKAP5 is highly expressed in the dendritic regions
of neurons of the forebrain. AKAP5 antibody was used in IHC to
demonstrate dendritic localization in the hippocampus (Fig. 2A)
and as expected the signal was lost in the KO. AKAP5 rich
regions, such as hippocampal dendrites, are also abundant in RII
subunits [6,27]. AKAP5 can bind either RIIa or RIIb subunits
with nanomolar affinity [28] and, as shown in the CA1 region of
WT hippocampus (Fig. 2B), RIIa (green) and AKAP5 (red)
Figure 1. Generation of AKAP5 KO and D36 mutant mice. A, Targeting strategy for generating AKAP5 KO mice. The neomycin selectable
marker (neo) replaces most of the coding sequence. Horizontal arrows represent the SacI (S) fragment detected in Southern Blotting. Probe
represents the region hybridized to radiolabeled external probe. B, The targeting strategy for AKAP5 D36 mice involved insertion of a stop codon
into the Akap5 coding sequence at position Leu710, as well as downstream insertion of the neo gene flanked by loxP sites (represented by black
triangles) for subsequent removal by crossing to rosa26 cre mice. The Leu710 position is denoted with an ‘‘X’’ because this mutation introduced an
XbaI site, which was used for genotyping, below. C, D, Southern blots confirmed the generation of the KO and D36 mice. E, PCR genotyping of the
KO mice relies on two separate reactions. The reaction labeled ‘‘akap’’ amplifies sequence in the WT allele. The reaction labeled ‘‘neo’’ amplifies
sequence in the KO allele. F, PCR genotyping of the D36 line of mice relies on an XbaI site created at the site of the D36 mutation. WT allele does not
cut with XbaI, whereas the D36 mutant allele is cut by XbaI. G, H, Western blots in AKAP5 KO and D36 mice. AKAP5 (N) terminal antibody recognizes
the N-terminus of AKAP5 that is still expressed in the D36 protein. AKAP5 (C) terminal antibody recognizes the C-terminus of AKAP5 that is lost in the
D36 protein.
doi:10.1371/journal.pone.0010325.g001
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AKAP5 are localized in both the apical and basal dendrites of
CA1 and CA2/3 neurons, with a paucity of staining in the cell
body of these pyramidal neurons. Figure 2C panel 1 (low power)
and panel 4 (higher power corresponding to the boxed area in
panel 1) show the distribution of RIIa in the hippocampus of WT
mice. In the D36 mice (panels 2 and 5) and KO mice (panels 3 and
6), the RIIa staining is shifted in the dendritic fields and becomes
concentrated in the cell body area of the pyramidal neurons (Fig. 2,
red arrows in panels 1–9 indicate the pyramidal cell layer). RIIb is
also expressed in the dendrites of CA1 and CA3 pyramidal
hippocampal neurons and we observe a similar shift in the RIIb
staining (panels 8 for the D36 and 9 for the KO, red arrows). At
high power this shift in RIIb localization leads to increased RIIb
staining in the cell body and in the dendritic shafts (Figure S1).
These shifts in RII localization indicate that both RIIa and RIIb
are anchored by AKAP5 in vivo and that other AKAPs are unable
to completely compensate and maintain normal dendritic
localization of RII subunits in these neurons.
It is known from in situ hybridization data that the granule cells
of the dentate gyrus express RIIb mRNA abundantly [29]. These
neurons give rise to the mossy fiber axons that project to CA3 and
RIIb protein appears to be localized out in the presynaptic
terminals of these projections (white arrows in Fig. 2C, panels 7–
9). RIIb localization in these presynaptic terminals was unaffected
in the AKAP5 mutant mice and this is consistent with the
observation that very little AKAP5 protein was associated with this
presynaptic region (Fig. 2A, black arrow).
Figure 2. Changes in localization of signaling molecules in KO and D36 mice. A, Nickel enhanced diamminobenzidine (DAB) staining using
an antibody against AKAP5 in the hippocampus of AKAP5 WT and KO mice. B, Immunohistochemistry (IHC) of RIIa, AKAP5, and the merged signal in
wild type mice. C, IHC in whole hippocampus of RIIa in WT (panel 1), D36 (panel 2), and KO (panel 3). Higher power IHC (representing the area boxed
in panel 1) of the CA1 region of RIIa in wild type (panel 4), D36 (panel 5), and KO (panel 6). IHC in whole hippocampus of RIIb in wild type (panel 7),
D36 (panel 8), and KO (panel 9). IHC in striatum of RIIb in wild type (panel 10), D36 (panel 11), and KO (panel 12). D, Western blot of 100,0006g
fractions (S is soluble fraction, P is particulate fraction) of RIIb and Ca in WT and KO striatal extracts (top panels) and a comparison of S and P fractions
from hippocampal tissue of WT and D36 mice (lower panel). E, Western blot of 100,0006g fractions of AKAP5 and RIIa in WT, KO, and D36
hippocampus (hpc). F, IHC in CA1 region ofAKAP5 D36 mutant protein localization in the hippocampus from a D36 mouse.
doi:10.1371/journal.pone.0010325.g002
Analysis of AKAP5 Mutant Mice
PLoS ONE | www.plosone.org 5 April 2010 | Volume 5 | Issue 4 | e10325RII localization by AKAP5 is not confined to the
hippocampus
In the striatum, AKAP5 is highly expressed and RIIb is the
predominant regulatory subunit [30]. RIIb was also delocalized
from dendritic regions of striatal medium spiny neurons and
redistributed to the cell body (Fig. 2C, panels 10–12). The PKA
delocalization that we see in the hippocampus and striatum is
consistent with a major role of AKAP5 in targeting RII-PKA to
dendritic sites.
If AKAP5 does target PKA to the PSD, which is a highly
insoluble protein-rich complex, we would expect that the amount
of PKA associated with particulate fractions might be reduced in
both the KO and D36 brain. AKAP5 has been shown to interact
with membrane proteins at the synapse as well as scaffolds at the
postsynaptic density (PSD) [7]. AKAP5, RIIa and RIIb have all
been shown to be associated with the PSD, and PSD preparations
from the forebrains of AKAP5 KO mice contain 60% less RIIa
and 90% less RIIb compared to WT mice [23]. Fig. 2D shows
western blots of particulate and supernatant fractions from the
striatum of WT and KO mice. In the WT mice, the majority of
the RIIb and Ca are located in the 100,0006g particulate fraction
(P), whereas in the KO mice the RIIb and Ca partitioning is
partially shifted into to the supernatant fraction (S) of striatal
extracts. In comparison, biochemical fractionation of the hippo-
campus did not show a substantial shift in partitioning of the RIIb
subunit in D36 animals (Fig. 2D, bottom). This finding is
consistent with the observation that the majority of the RIIb
protein in the hippocampus appeared to be localized presynap-
tically in mossy fiber axon terminals (white arrow, panels 7–9).
This presynaptic RIIb pool does not depend on AKAP5 for proper
localization. Figure 2E shows RIIa delocalization in the
hippocampus of KO and D36 mice. In the hippocampus (hpc)
AKAP5 is associated with the particulate pool (top panel) and a
portion of the particulate pool of RIIa seen in WT mice was
shifted to the soluble fraction (S) in the KO and D36 mice (bottom
panel). These shifts towards the supernatant in the mutant mice
are consistent with the hypothesis that AKAP5 plays a non-
redundant role in targeting PKA to the PSD in both the striatum
and hippocampus. The lack of RII-PKA localization in the D36
mutant was not due to mis-folding or mislocalization of the D36
mutant itself as shown by IHC staining of D36 protein in the
hippocampus (Fig. 2F), which is similar to AKAP5 staining in WT
hippocampus, as seen in Fig. 2B. This agrees with previously
published results demonstrating that the N-terminal domains in
AKAP5 are important in membrane targeting [25]. A more
central region in the AKAP5 protein that is also still expressed in
the D36 protein is responsible for binding to MAGUK proteins
such as PSD-95 and SAP97 located in the PSD [8].
Compensatory changes in other AKAPs or PKA subunits
are not detected in AKAP5 mutants
Animals surviving with a genetic mutation often develop
compensatory changes that help to restore function. For example,
our lab has reported that RIIb and RIIa KO mice display up-
regulation of RI subunits [31,32]. Although the IHC results argue
that AKAP5 is indispensable for PKA anchoring to dendrites,
changes in expression of other AKAPs or PKA might occur in
response to the AKAP5 mutations. An RII overlay assay was
employed as a general approach to detect whether there are
changes in other AKAPs. The results are shown for KO and WT
animals in hippocampus (Fig. 3A) and striatum (Fig. 3B). The
overlay assays show that AKAP5 is a major AKAP in the
hippocampus. There were multiple AKAPs detected a low (7 nM)
concentration of RIIb, but there was no evidence for compensa-
tory increases in other AKAPs in the KOs. The specificity of RIIb
binding for AKAPs was tested by including Ht-31 in the overlay
incubation, which disrupts AKAP-PKA interactions. Although
there are other AKAPs that could be playing a role in anchoring
PKA to dendrites, these findings suggest that other AKAPs are not
upregulated to compensate for the loss of AKAP5. AKAP7
(AKAP15/18) shares some of the properties of AKAP5 including
membrane association, dendritic localization and ion channel
interactions [33,34] and we therefore examined its expression
directly by western blot and overlay assay and found no changes in
AKAP7 in WT, KO, or D36 mice (unpublished data).
Delocalization of PKA might also lead to compensatory changes
in PKA-R subunit levels and western blots were performed on
brain extracts from WT, KO, and D36 mice to examine this
possibility. There were no changes in any of the other PKA- R
subunits (Fig. 3C for KO, 3D for D36). PKA activity in the
striatum of KO and D36 mice was also unaltered (Fig. 3E). Basal
PKA activity (2 cAMP lanes) can be indicative of free C subunits,
and cAMP induced activity (+ cAMP lanes) reflects the total PKA
in the tissue. From these data it appears that RII delocalization
does not perturb general PKA levels or activity.
Alterations in dendritic protein interactions in AKAP5
mutant mice
AKAP5 protein domains that interact with other signaling
molecules, such as calcineurin, have been mapped to regions still
present in the D36 protein [2,4,35,36,37,38]. Therefore we
expected that the D36 protein would interact normally with these
proteins in vivo even though it no longer interacts with PKA. To
test this biochemically, a co-immunoprecipitation experiment was
done to determine whether the D36 mutant was still able to
interact with calcineurin in vivo and confirm that PKA was no
longer binding (Fig. 4A). As a control we showed that
immunoprecipitation of AKAP5 brought down calcineurin and
RIIa as expected (Fig. 4A). Immunoprecipitation of the D36
protein brought down calcineurin but not RIIa and this was
confirmed with reciprocal immunoprecipitations of calcineurin
and RIIa (Fig. 4A). These results suggest that there are no other
major AKAPs in hippocampus that bind both RIIa and
calcineurin and confirm that the D36 AKAP5 protein can still
interact with calcineurin. Together with the IHC data showing
proper D36 localization (Fig. 2F), these results demonstrate that
the D36 protein is targeting calcineurin, but not PKA, to AKAP5
target sites.
To more carefully characterize PKA interactions in dendrites,
we performed co-immunoprecipitations of AKAP5 and PKA with
markers of the PSD and the major AKAP of the dendritic shaft,
MAP2. In hippocampal dendrites, RIIa is the major RII subunit
anchored by AKAP5 and in the AKAP5 KO most of the RIIa
moves to the cell body and dendritic shafts suggesting that it may
have translocated to other AKAPs. Early biochemical studies
showed that only a small percentage of MAP2 is bound by RII
subunits in WT mice [39] so we tested whether this might increase
in the AKAP5 KO. We found a significant increase in the
association of RIIa with MAP2 in the AKAP5 KO hippocampal
extracts whereas the association between RIIa and GluR2/3 was
diminished (Fig. 4B). Interestingly, MAP2 showed a weak
association with AKAP5 itself. These interactions could be
occurring during the kinesin-mediated trafficking of PSD compo-
nents along microtubules [40], or might take place in dendritic
spines [41]. AKAP5 also associates with PSD-95 and GluR2/3 by
immunoprecipitation but the interaction between GluR2/3 and
PSD-95 is not disrupted in the AKAP5 KO. This agrees with
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associate directly [42] or indirectly [43] with AMPA receptors.
Additionally, MAGUK proteins can interact with AKAP5, which
brings PKA and calcineurin into these AMPA receptor complexes
[7,8,44].
D36 mutant mice exhibit impaired hippocampal LTP and
LTD compared with either WT or AKAP5 KO mice
Pharmacologic inhibition of PKA-AKAP interactions can
disrupt hippocampal plasticity [45]. We have previously shown
that 8 week old D36 mice have a deficit in CA1 LTP [23].
Unexpectedly, we found that the AKAP5 KO mice did not have a
detectable deficit in LTP using the same induction paradigm
(Figure S2, A). Summary results of fEPSP data elicited before and
after a single tetanus (1 sec/100 Hz) showed that Schaffer
Collateral-CA1 (SC-CA1) LTP was deficient only in the D36
mice (Fig. 5A). These studies on the KO and D36 mice were done
in parallel and therefore cannot be explained by different
experimental conditions. We have also published results showing
that the D36 mice showed a deficit in LTD at age 2 weeks [24].
Again, in contrast, the KO animals displayed normal LTD (Figure
S2, B). The LTD data for both KO and D36 are summarized in
Fig. 5B. The electrophysiological deficits in both LTP and LTD
are specific to the D36 mice, and the KO mice exhibit essentially
normal LTP and LTD under these stimulating conditions. We
conclude that the D36 mice have an electrophysiological defect
compared to KO mice of the same age.
Spatial learning and short-term memory are intact in the
D36 mice
Spatial learning requires intact PKA signaling in the hippo-
campus [46] and deficits in hippocampal LTP and LTD in mutant
mice often correlate with deficits in spatial learning and memory
tasks [47]. Therefore we assessed spatial learning and memory in
the D36 mice by testing them in the Morris Water Maze. Both
D36 and the WT littermate controls showed indistinguishable
Figure 3. Lack of compensatory upregulation of PKA or other AKAPs in AKAP5 KO and D36 mice. A, RII overlay assay in WT or KO
hippocampal extracts probed with RIIb at a concentration of 7 nM with Ht-31 (+ lane) or without Ht-31 (2 lanes). B, RII overlay assay in WT or KO
striatal extracts probed with RIIb under the same conditions as in A. C, Western blots of PKA regulatory subunits in cortex (ctx), hippocampus (hpc),
striatum (str), or cerebellum (cbl) in WT and KO extracts. D, Western blots of PKA regulatory subunits in cortex (ctx), hippocampus (hpc), striatum (str),
or cerebellum (cbl) in WT and D36 extracts. E, PKA activity assay representing specific activity to phosphorylate Kemptide in WT, KO, and D36 striatal
extracts. Basal phosphorylation is measured in the absence (2 lanes) of exogenous cAMP, and total kinase activity is measured by the addition (+
lanes) of 5 mM cAMP.
doi:10.1371/journal.pone.0010325.g003
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platform during a 9-day training period (Fig. 6A). The probe trial
was done on the 10
th day, and both D36 and WT mice showed an
equivalent preference for the quadrant that previously housed the
hidden platform (Fig. 6B). These results show that despite PKA
delocalization and deficient LTP and LTD in the hippocampus,
the D36 mice exhibited intact spatial learning and memory in the
Morris Water Maze.
Learning and memory in the water maze task took place over
nine consecutive days, after which the behavior was well
entrained. We reasoned that the D36 LTP and LTD deficits
might manifest in a behavior requiring short-term memories after
a single trial. Novel object recognition is a test of short-term
memory and has been shown to be impaired in rodents with
hippocampal lesions [48]. Novel object exploratory behavior
facilitates LTD in awake behaving animals at the rat SC-CA1
synapse and inhibition of LTD in this paradigm prevents
habituation to novel stimuli [49]. However, the D36 mice
performed this test as well as controls indicating that the D36
mice have intact short-term memory as measured by the ratio of
the time spent at the novel object compared to the familiar object
(Fig. 6C).
Open field testing can also be used to measure anxiety which
may affect other behavioral tests. Adenylate cyclase 5 (AC5) is
highly expressed in the striatum as is AKAP5 and AC5 KO mice
show reductions in several anxiety like behaviors [50]. Persever-
ance near the edges or walls of the illuminated open field was
measured and we found no differences between D36 and WT in
this test (Fig. 6D) indicating that D36 mice exhibit normal
exploratory behavior and do not show heightened anxiety. Despite
the deficits in hippocampal LTP and LTD in the D36 mice, their
spatial learning, and anxiety related behaviors remained intact.
Since AKAP5 is most highly expressed in the ventral and dorsal
striatum where it colocalizes with RIIb [6] we tested whether
AKAP5 mice would exhibit deficiencies similar to those seen in
RIIb KO mice. The RIIb KO mice have increased locomotor
sensitization to amphetamine, deficient rotarod performance, and
Figure 4. Signaling complexes in WT and AKAP5 mutant hippocampus. A, Immunoprecipitation (IP) of AKAP5, calcineurin (CaN), and RIIa,
with immunoblotting (IB) using antibodies against CaN, AKAP5, and RIIa. Input is the equivalent amount of hippocampal extract. B, IP of the dendritic
shaft AKAP MAP2, AKAP5, a PSD enriched protein, GluR2/3, and RIIa, with immunoblotting (IB) using antibodies against AKAP5, PSD-95, RIIa, MAP2,
and GluR2/3. IP’s are 7.5 fold more concentrated relative to the inputs, to facilitate visualization and comparison of the WT vs. KO extracts, as well as
to detect weaker interactions.
doi:10.1371/journal.pone.0010325.g004
Figure 5. AKAP5 D36, but not KO mice, have impaired
hippocampal LTP and LTD. A, LTP induced by stimulation of
Schaffer collaterals in the CA1 area for 1 sec at 100 Hz in brain slices
from KO and D36 mice compared to their littermate controls. Summary
LTP comparison data from 7–12 week old KO and D36 mice and their
respective littermate controls. B, LTD induced by stimulation of Schaffer
collaterals in the CA1 area for 15 min at 1 Hz in brain slices from KO and
D36 and WT control mice. Summary LTD data from 10–14 day old KO
and D36 mice and their littermate controls. For each recording averages
of the initial slopes measured 55–60 min after LTP or LTD induction
were compared to those of the 5 min preceding LTP or LTD induction;
* represents p,.05, one way ANOVA for LTP data and independently for
LTD data comparing WT, KO, and D36 mice.
doi:10.1371/journal.pone.0010325.g005
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association between AKAP5 and RIIb, the AKAP5 KO and D36
mice displayed normal behavior in all of these tests (Figure S3, and
data not shown).
Reversal learning is impaired in D36 mice but not in KO
mice
There are lines of mice that, like the D36 and KO mice, show
deficits in hippocampal electrophysiology, yet remain within
normal limits on most standard tests of memory, learning, and
behavior. GluR1 mutant mice are one such example, where
standard tasks like the Morris Water Maze fail to identify deficits
yet certain forms of hippocampal LTP are compromised [52,53].
However, GluR1 KO and a GluR1 mutant mouse that eliminates
phosphorylation sites for PKA and PKC (GluR1 Ser845 and
Ser831, respectively) exhibit behavioral deficits when faced with
more complex behavioral tasks involving reversal learning [52,54].
Therefore we challenged the KO and D36 mice to operant
conditioning for food reward and reversal learning using this task.
In the training phase, naive WT and AKAP5 mutant mice were
each given a daily 20 min trial over 12 consecutive days to learn to
press one of two levers for food. Correct lever presses are shown
for WT vs. KO (Fig. 7A) and WT vs. D36 mice (Fig. 7B). Both the
KO and D36 mice exhibited similar performance in the training
phase of this task compared to their WT littermate controls. After
this 12 day training phase, the active lever was switched such that
the mice had to press a different lever to deliver the food reward.
Reversal learning requires behavioral flexibility: the mice need to
adapt their previously learned behavior to stop pressing the old
active lever and begin pressing the new active lever for food
reward. In this task the KO mice showed no deficit and learned to
press the new active lever at the same rate as their WT controls
(Fig. 7C). However the D36 mice showed a delayed acquisition in
reversal learning relative to WT controls (Fig. 7D). This deficit was
during the initial period of days where the rate of acquisition, or
learning, for the new lever was at a maximum. After this initial
phase (days 1–4) of reversal learning the D36 mice catch up and
begin to perform the task comparable to their WT littermate
controls (days 5–8, Fig. 7E). The D36 deficiency in reversal
learning can also be viewed as a lack of discrimination between the
active and inactive levers. Discrimination is defined as the fraction
of correct lever presses, where a value of 0.5 represents equal
correct vs. incorrect (random) lever pressing. Discrimination is
shown for the task comparing KO (Fig. 7F) and D36 (Fig. 7G) to
WT controls. As expected, discrimination by the KO mice in this
task was similar to their WT controls and increased comparably
over days 1–4 of the reversal learning task. However, the D36
mice were deficient as indicated by lever discrimination during the
initial phase and then caught up with the WT group on days 5–8
(Fig. 7H). In the initial phase of the reversal paradigm, the
discrimination for all groups of mice started well below 0.5,
demonstrating that the mice were still favoring the previously
Figure 6. Normal spatial learning, short-term memory, and open field behaviors in AKAP5 D36 mice. A, Water maze learning as
measured by the latency to find a hidden platform over 9 consecutive days, three trials per day, in D36 vs. WT littermate controls. Each training trial
was 3 min. Data are plotted as the average of the three trials on each day. ANOVA reports a significant effect of day: F (8, 198)=10, p,.001, but not
genotype: F (1, 198)=.02, p=.88 on the latencies to the platform. B, Probe trial (one day after last training trial) as measured after removing the
platform and counting time spent in the quadrants (quadrant II housed the platform), for D36 and littermate WT controls. Probe trial consisted of a
single two-minute trial per animal on day 10, which was 24 hours after the last training day. Data are plotted as the percent time the animals spent in
each quadrant. ANOVA reports only a significant effect of quadrant: F (3, 88)=11.9, p,.05, Bonferonni post hoc test for quadrant II, and no significant
effect of any other quadrant or of genotype on the probe trial: F (1, 88)=.01, p=.96 C, Novel object recognition as measured by the time spent in an
area containing a novel object (n.o.) compared with a comparable area housing a familiar object (f.o.). Ratio is the fold increase in time spent in the
area of the novel object. ANOVA analysis reports no effect of genotype on novel object preference. D, Open field testing measures the percent time
spent toward the center of the arena (cen) vs. near the edge of the arena walls (out), with crossings equaling the number of times mice went from the
edge area into the center area. Open field trials lasted 5 minutes. ANOVA analysis reports no effect of genotype on open field behavior.
doi:10.1371/journal.pone.0010325.g006
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box where lever pressing for food reward is plotted. Correct lever presses are plotted for 12 consecutive days. Since the reinforcement schedule was
FR=1, this equals the number of food pellets dispensed. B, Correct lever presses during the initial learning phase for D36 and WT littermate controls
in the same paradigm. C, Correct lever presses during the reversal learning phase plots performance after the active lever is switched (day 13),
marking the beginning of the reversal learning phase. KO and WT littermate controls plotted during the first four consecutive days of the reversal
learning. D, D36 and WT littermate controls plotted during the first four consecutive days of the reversal learning. E, Correct lever presses of the D36
and WT littermate controls, plotted for days 5–8 during the reversal learning. F, Discrimination represented as the fraction of correct lever presses
during days 1–4 of the reversal-learning phase for KO and WT littermate controls. G, Discrimination during days 1–4 of the reversal-learning phase for
D36 and WT littermate controls H, Discrimination during days 5–8 of the reversal-learning phase for D36 and WT controls. The data shown in C–E
collected from the same trials used in calculating discrimination in F–H. * represents p,.05, Two Way ANOVA with Bonferroni’s Post Test. A, B, For
correct lever pressing during the initial learning, there is a significant effect of training day: KO group; F (11, 192)=18.0, p,0.001, D36 group; F (11,
444)=44.7, p,0.001, but no significant effect of genotype: KO group; F (1, 192)=.01, p=.93, D36 group; F (1, 444)=.11, p=.75. C, D, For correct
lever pressing during the reversal learning, there is a significant effect of training day: KO group; F (3, 64)=16.3, p,0.001, D36 group; F (3, 148)=35.9,
p,0.001. There is no significant effect of genotype for the KO group; F (1, 64)=.17, p=.68, but there is a significant effect of genotype in the D36
group compared to their WT littermate controls; F (1, 148)=8.65, p=.004. F, G, For discrimination on days 1–4 of reversal learning, there is a
significant effect of training day: KO group; F (3, 64)=27.1, p,0.001, D36 group; F (3, 148)=90.0, p,0.001. There is no significant effect of genotype
for the KO group; F (1, 64)=.03, p=.87, but there is a significant effect of genotype in the D36 group compared to their WT littermate controls; F (1,
148)=22.6, p,.05.
doi:10.1371/journal.pone.0010325.g007
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presses during first days of reversal learning. The discrimination
increased over subsequent days for all mice, but the D36 mice
were deficient compared to WT littermate controls only in the rate
of acquisition of the new task (days 1–4). The KO mice showed no
deficit during this time of reversal learning. KO, D36 and WT
mice all reached similar levels of correct lever and discriminative
performance after 5 days. These data show that during the
reversal-learning trial, when the task requires behavioral flexibility,
D36 mice have a significant learning deficit compared with WT
and more interestingly, the KO mice. This behavioral deficit
correlates with the D36 deficits in hippocampal LTP and LTD
and suggests that mutation of the PKA docking site on AKAP5 has
created a negative effect on synaptic plasticity and behavior that is
not seen in the complete AKAP5 KO. We speculate that releasing
PKA but retaining the other signaling components including
calcineurin may lead to this negative effect on function.
Discussion
PKA and, more recently, AKAPs, have been shown to be
important in neuronal function and plasticity. We have created
two lines of AKAP5 mutant mice (KO and D36) that are
informative in understanding the roles of this scaffolding molecule
in intracellular signaling. KO mice lack the protein completely and
therefore the entire AKAP5 signaling complex is disrupted. D36
mice express a mutant protein that is missing the PKA binding
domain but continues to bind and localize other signaling
molecules including the phosphatase, calcineurin. The defining
feature of AKAPs is that they bind to and target PKA to specific
sites within a cell and AKAP5 is one of the most abundant high
affinity AKAPs in the forebrain as demonstrated by RII overlay
(Fig. 3A, B). In both mutant mouse lines there is a dramatic
relocalization of RIIa and RIIb from dendritic regions to the cell
bodies in the hippocampus and striatum (Fig. 2C), which is
consistent with our previous findings of reduced RIIa and RIIb in
PSD complexes isolated from AKAP5 mutant mice [23]. We
found no evidence for a compensatory up regulation of other
AKAPs (Fig. 3) and the delocalization of PKA indicates that
AKAP5 is a predominant binding partner for PKA in forebrain
dendritic processes.
Despite the uncompensated PKA delocalization, these AKAP5
mutant mice are remarkably unaffected. No changes in body
weight, fertility, or growth rates were evident. As one of the major
binding partners of AKAP5 is the RIIb subunit of PKA we tested
whether any of the well-studied RIIb KO phenotypes might be
recapitulated in the AKAP5 KO or D36 mutants. The RIIb KO
mice are deficient in rotarod learning and haloperidol-induced
catalepsy, and they are lean and hyperactive [22,32,51,55]. None
of these phenotypes were observed in either the AKAP5 KO or
D36 mutant mouse lines (Figure S3) indicating that the phenotypes
of the RIIb KO are not likely to be caused by loss of PKA
localization to AKAP5 in these animals.
Previously we reported that the D36 mice display deficits in
hippocampal LTP and LTD at the SC-CA1 pathway [23,24]. The
defects in LTP were only seen in adult (8 wk) animals whereas
LTP in 4 wk old mice remained intact. This age-dependent deficit
was in agreement with the requirement for PKA to elicit LTP at 8
weeks but not at 4 weeks of age when using a single 100 Hz/1 sec
tetanus [23] and the observations that GluR1 KO and GluR1
knockin mutants that eliminate phosphorylation sites (S831A,
S845A) also show a similar age-dependent LTP deficit in adult but
not young animals [56]. Examination of LTD in 2 wk old mice
also demonstrated a substantial deficit in the D36 mice. However,
when we examined the AKAP5 KO mice under the same
conditions we found that both LTP in adult and LTD in 2 wk old
mice were intact (Fig. 5). This was an unexpected result and
implies that the PKA binding site mutation in the D36 animals is
causing a gain of function effect on synaptic plasticity which is not
seen when the protein is eliminated in the KO.
As electrophysiological deficits often correlate with behavioral
deficits, we examined whether the D36 mice might have more
pronounced behavioral defects compared with KO mice. The D36
animals did not appear to have deficits in simple learning tasks
including novel object recognition or Morris Water Maze (Fig. 6),
so we tested them in a more complex operant conditioning
paradigm that required reversal learning. Mice were trained to
press one of two levers for a food reward and the acquisition of this
task was similar for WT, KO and D36 animals. However, when
the reward lever was reversed, the D36 mice were deficient in their
ability to relearn the task compared with WT and KO mice
(Fig. 7). This behavioral deficit, specific to the D36 mice, correlates
with their deficiency in both hippocampal LTP and LTD when
compared with either WT or KO mice.
One hypothesis to explain the more severe electrophysiological
and behavioral effects of the D36 mutant is illustrated in Fig. 8.
AKAP5 binds both kinases (PKA and PKC) and a phosphatase
(calcineurin) and we suggest that the kinase/phosphatase balance
in the dendritic spine is critical in the regulation of downstream
targets. Because the D36 mutant protein can target calcineurin but
not PKA, it has the ability to act as a quasi dominant negative
scaffold on targets that can be bidirectionally regulated, such as the
GluR1 type of AMPAR. In the KO spines, neither the kinase nor
the phosphatase can regulate targets through AKAP5 targeting. In
D36 mutant spines, however, the AKAP targets the phosphatase
without PKA and this imbalance might be responsible for the D36
dominant effects. Both PKA and calcineurin bind to AKAP5 and
have been shown to be key regulators of GluR1 currents [57].
PKA and calcineurin act in opposition to each other to determine
the relative GluR1 current by regulating trafficking to and from
the plasma membrane as well as affecting single channel
properties. In the complete AKAP5 KO both PKA and
calcineurin would be released from their anchored sites in
proximity to the AMPAR and we postulate that the mice with
this congenital defect are able to partially compensate although
that compensation does not appear to entail movement of a
substantial fraction of PKA back to the normal dendritic sites.
Interestingly, GluR1 mutant mice with targeted mutations in
the sites for PKA (S845A) and CaMKII (S831A), display a partial
defect in hippocampal LTP and a complete deficit in LTD [52].
These GluR1 mutants exhibit normal Morris Water Maze
learning and memory but display more subtle deficits in spatial
learning when animals are required to learn and remember a new
platform location [52,54]. The electrophysiological and behavioral
phenotypes of the GluR1 (S845A/S831A) mutants are quite
similar to the phenotypes we observed for the AKAP5 D36
mutants, and is consistent with results showing that inhibitors of all
PKA/AKAP interactions can disrupt synaptic plasticity and
certain forms of spatial memories [58].
AKAP5 scaffolded molecules such as PKC, PKA, and
calcineurin are able to act on GluR1, and we have previously
shown that forskolin induced GluR1 phosphorylation is reduced in
the D36 mice [23]. However, the hypothesis that the D36
phenotypes might be due solely to dysregulation of AMPAR
phosphorylation is an oversimplification, as there are numerous
other PKA and calcineurin substrates near the PSD that can affect
synaptic plasticity, including stargazin, NR1 subunits of the
NMDAR, b-ARs, and L-type calcium channels [12,59,60,61].
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PKGII, can phosphorylate GluR1 at Ser 845 and increase surface
expression of GluR1, downstream of NMDAR activation [62].
Thus there are parallel mechanisms acting on GluR1, which affect
synaptic plasticity. However, the GluR1 pools that act as PKA and
PKG substrates might be different, as deleting the SAP97
interacting domain on GluR1 abrogates PKA, but not PKG
phosphorylation of GluR1 at Ser845 [62]. It has recently been
shown that AMPAR internalization also requires AKAP5-PSD95
and AKAP5-calcineurin interactions [63]. Together, these results
demonstrate that bidirectional AMPAR regulation by PKA and
CaN requires targeting of these two proteins via AKAP5
interactions within the PSD domain. Our unexpected result
demonstrating the gain of function effects in the D36 mutant
compared to the KO underscores the complexity of analyzing
mouse mutants of the AKAP scaffolding proteins since they
assemble with multiple signaling partners that may interact with
each other as well as potential substrates.
During the course of our investigation, Tunquist et al generated
an AKAP5 KO and reported alterations in PKA localization,
hippocampal LTD, AMPAR rundown, M-current suppression,
and several behavior tasks [64]. Our studies on the AKAP5 KO
agree with those of Tunquist et al on the delocalization of PKA
and the apparent lack of substantial AKAP compensation but
differ in the analysis of LTD and behavior. The role of PKA and
other signaling pathways in hippocampal electrophysiology
changes during early development [23]. Our LTD studies were
done with very young (10–14 day-old) mice whereas the Tunquist
study was done with adults and this may contribute to differences.
Clearly the KO mice do have phenotypes and we have
demonstrated neuronal, vascular, and cardiac abnormalities.
The KO mice display deficits in neuronal L-type calcium channel
phosphorylation in response to b-agonists [12], defective regula-
tion of vascular smooth muscle by angiotensin II through a PKC
dependent pathway [65], and loss of b-adrenergic enhanced
calcium-induced calcium release in ventricular cardiomyocytes (B.
Nichols and GSM, unpublished). Taking our studies together with
those of Tunquist et al [64], we suggest that both the KO and D36
exhibit electrophysiological and behavior deficits that are depen-
dent on animal age, the specific behavioral task employed, and
perhaps other parameters such as genetic background.
In a recent paper, the localization of type II PKA was analyzed
at high resolution in dendritic shafts and spines using both cultured
neurons and an in vivo approach with transfected PKA subunits
[66]. The authors conclude that MAP2 is the major type II PKA
binding AKAP in neurons and localizes the kinase to the dendritic
shafts and excludes PKA from spines. Our results and those of
Tunquist et al are not consistent with this recent report [64]. It is
clear that MAP2 is an important dendritic AKAP that plays a
substantial role in type II PKA localization in dendrites [39] and
MAP2 mutant mice have decreased dendritic PKA [67]. An
amino-terminal deletion mutant of MAP2 that removes the PKA
binding site, leads to PKA delocalization from dendrites as well as
behavioral effects [68]. However, these MAP2 knockout and
mutant mice also have striking deficits in dendritic elongation and
dendritic architecture [69,70] that could contribute to the
mislocalization of PKA and perhaps the mislocalization of other
scaffolding proteins such as AKAP5.
Our results show a dramatic delocalization of type II PKA
subunits in the AKAP5 knockout and D36 mice. Since MAP2
mutants also affect PKA localization, we conclude that MAP2 and
AKAP5 are probably working in concert to localize PKA in
dendrites. One intriguing possibility comes from our observation
that a fraction of AKAP5 is associated with MAP2 suggesting that
MAP2 might be binding and facilitating the microtubule-
dependent transport of synaptic components to the dendritic
spines.
In this study, we describe phenotypic responses that underscore
the importance of the balance between the opposing activities of
kinases and phosphatases at the post-synaptic terminals. AKAP5 is
likely to play a key role in mediating this bidirectional plasticity
that occurs both in response to electrical stimulation paradigms
[71] and in vivo following learning [72]. The AKAP5 KO and
D36 mice described here provide a valuable tool to dissect the role
of this AKAP in dendritic localization of PKA and other AKAP5
binding partners and together with other mutant AKAP mice may
Figure 8. Model of the AKAP5 scaffold domain at the PSD in WT, AKAP5 KO, and AKAP5 D36 mutant mice. In the WT mice, AKAP5
anchors both PKA and CaN to PSD95 in proximity to AMPARs. There are other AKAPs and other CaN binding proteins associated with PSDs that can
also bind PKA and CaN, respectively. In the AKAP5 KO PSD domains, the relative amounts of PKA and CaN are reduced and PKA redistributes to empty
MAP2 binding sites in the dendritic shafts and to the cell body. In the D36 PSD’s, because AKAP5D36 still binds CaN, there is an imbalance favoring
increased phosphatase activity with PKA showing the same redistribution seen in the KO.
doi:10.1371/journal.pone.0010325.g008
Analysis of AKAP5 Mutant Mice
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for synaptic plasticity.
Supporting Information
Figure S1 Relocalization of RIIb subunits in the cell body area
and dendritic shaft in KO CA1 pyramidal neurons. Immunohis-
tochemistry of RIIb at high power in pyramidal CA1 neurons.
RIIb staining is shown at the cell body and proximal apical
dendritic region in WT vs. KO neurons
Found at: doi:10.1371/journal.pone.0010325.s001 (1.24 MB TIF)
Figure S2 SC/CA1 LTP and LTD from AKAP5 KO
hippocampal slices are normal. A, Summary traces before (light
traces) and 60 minutes after (dark traces) LTP induction. B,
Summary traces in WT vs. KO mice before (light traces) and 60
minutes after (dark traces) the LTD induction protocol.
Found at: doi:10.1371/journal.pone.0010325.s002 (2.25 MB TIF)
Figure S3 Normal motor learning and drug induced motor
response in AKAP5 KO and D36 mice. A, Motor learning and
memory was measured by repeated trials on an accelerating
rotarod over two consecutive days in AKAP5 KO and D36 mice
compared to their WT littermate controls. Day 1 trials assess
learning of the task, and day 2 trials assess memory for the task
over the 24-hour period as well as peak performance on the
rotarod. ANOVA analysis shows significant effect of day 1 trials
for KO group: F (5,132)=38.1, p,0.001, and for D36 group: F
(5,132)=27.2, p,0.001 but no genotype effect on day 1 trials for
KO (p=.71) or D36 (p=.64) mice. There was no significant effect
on day 2 for trial or for genotype. B, Cataleptic motor response to
a haloperidol challenge in KO and D36 mice compared to their
WT littermate controls. Responders are mice that maintain a
semi-upright posture for 20 seconds when placed in that position
by the experimenter. Haloperidol dose was 4 mg/kg delivered by
IP injection, and motor behavior was assessed 15 minutes, 1, 3,
and 7 hours after IP injection.
Found at: doi:10.1371/journal.pone.0010325.s003 (1.80 MB TIF)
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